176 related articles for article (PubMed ID: 19639032)
1. Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma.
Meyer S; Vogt T; Landthaler M; Berand A; Reichle A; Bataille F; Marx AH; Menz A; Hartmann A; Kunz-Schughart LA; Wild PJ
PPAR Res; 2009; 2009():848645. PubMed ID: 19639032
[TBL] [Abstract][Full Text] [Related]
2. Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFkappaB signal disruption in human WISH and amnion cells.
Ackerman WE; Zhang XL; Rovin BH; Kniss DA
Biol Reprod; 2005 Sep; 73(3):527-35. PubMed ID: 15843495
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma during malignant melanoma progression.
Lee C; Ramirez JA; Guitart J; Diaz LK
J Cutan Pathol; 2008 Nov; 35(11):989-94. PubMed ID: 18537861
[TBL] [Abstract][Full Text] [Related]
4. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis.
Ogino S; Shima K; Baba Y; Nosho K; Irahara N; Kure S; Chen L; Toyoda S; Kirkner GJ; Wang YL; Giovannucci EL; Fuchs CS
Gastroenterology; 2009 Apr; 136(4):1242-50. PubMed ID: 19186181
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome.
Pancione M; Sabatino L; Fucci A; Carafa V; Nebbioso A; Forte N; Febbraro A; Parente D; Ambrosino C; Normanno N; Altucci L; Colantuoni V
PLoS One; 2010 Dec; 5(12):e14229. PubMed ID: 21151932
[TBL] [Abstract][Full Text] [Related]
7. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
[TBL] [Abstract][Full Text] [Related]
8. Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial.
Walter I; Schulz U; Vogelhuber M; Wiedmann K; Endlicher E; Klebl F; Andreesen R; Herr W; Ghibelli L; Hackl C; Wiest R; Reichle A
Med Oncol; 2017 Nov; 34(12):192. PubMed ID: 29098441
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.
Bauer R; Wild PJ; Meyer S; Bataille F; Pauer A; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
J Clin Pathol; 2006 Jul; 59(7):699-705. PubMed ID: 16565225
[TBL] [Abstract][Full Text] [Related]
10. High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer.
Elzagheid A; Emaetig F; Alkikhia L; Buhmeida A; Syrjänen K; El-Faitori O; Latto M; Collan Y; Pyrhönen S
Anticancer Res; 2013 Aug; 33(8):3137-43. PubMed ID: 23898071
[TBL] [Abstract][Full Text] [Related]
11. Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study.
Jonsson L; Bergman J; Nodin B; Manjer J; Pontén F; Uhlén M; Jirström K
J Transl Med; 2011 Jul; 9():114. PubMed ID: 21777469
[TBL] [Abstract][Full Text] [Related]
12. UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression.
Sabatino L; Fucci A; Pancione M; Carafa V; Nebbioso A; Pistore C; Babbio F; Votino C; Laudanna C; Ceccarelli M; Altucci L; Bonapace IM; Colantuoni V
Oncogene; 2012 Dec; 31(49):5061-72. PubMed ID: 22286757
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
[TBL] [Abstract][Full Text] [Related]
14. [Expression of COX-2 and PPARg in the livers of patients with acute on chronic HBV-related liver failure and their relationship with clinic parameters].
Niu YH; Yi RT; Liu HL; Chen TY; Zhang SL; Zhao YR
Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):511-6. PubMed ID: 22152242
[TBL] [Abstract][Full Text] [Related]
15. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.
Hollingshead HE; Borland MG; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Carcinogenesis; 2008 Jan; 29(1):169-76. PubMed ID: 17893232
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and immunological significance of peroxisome proliferator-activated receptor gamma in hepatocellular carcinoma based on multiple databases.
Wang C; Yu S; Qian R; Chen S; Dai C; Shan X
Transl Cancer Res; 2022 Jul; 11(7):1938-1953. PubMed ID: 36249888
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor (PPAR) isoforms are differentially expressed in peri-implantation porcine conceptuses.
Blitek A; Szymanska M
Theriogenology; 2017 Oct; 101():53-61. PubMed ID: 28708516
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Bhattacharya T; Arora J; Yadav S; Chhoker V; Kumar A; Dhanaraj PS; Yadavilli KS; Verma M
Histopathology; 2016 Aug; 69(2):268-75. PubMed ID: 26791964
[TBL] [Abstract][Full Text] [Related]
19. Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma.
Meyer S; Wild PJ; Vogt T; Bataille F; Ehret C; Gantner S; Landthaler M; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
Exp Dermatol; 2010 Aug; 19(8):e251-7. PubMed ID: 20500769
[TBL] [Abstract][Full Text] [Related]
20. COX2 overexpression is a prognostic marker for Stage III breast cancer.
Kim HS; Moon HG; Han W; Yom CK; Kim WH; Kim JH; Noh DY
Breast Cancer Res Treat; 2012 Feb; 132(1):51-9. PubMed ID: 21533532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]